GXMC
SAGE

Global X Management Company’s Sage Therapeutics SAGE Stock Holding History

Global X Management Company’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$94K Buy
603
+179
+42% +$28.1K ﹤0.01% 1016
2018
Q1 		$68K Buy
424
+106
+33% +$18K ﹤0.01% 984
2017
Q4 		$52K Buy
318
+73
+30% +$7.08K ﹤0.01% 913
2017
Q3 		$15K Buy
245
+35
+17% +$2.75K ﹤0.01% 1086
2017
Q2 		$17K Buy
210
+79
+60% +$5.71K ﹤0.01% 1180
2017
Q1 		$9K Buy
131
+7
+6% +$410 ﹤0.01% 1158
2016
Q4 		$6K Hold
124
– – ﹤0.01% 1052
2016
Q3 		$6K Hold
124
– – ﹤0.01% 1051
2016
Q2 		$4K Buy
+124
New +$4.13K ﹤0.01% 960

Other funds holding SAGE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return